Gastroesophageal Rexlux Disease and Barretdysplasia after laparoscopic Sleeve Gastrectomy

Recruiting

• Conditions: K21.0; R12; Gastro-oesophageal reflux disease with oesophagitis; Heartburn

• Registration Number: DRKS00017149
• Lead Sponsor: Allgemein- und Viszeralchirurgie Klinikum Vest Knappschaftskrankenhaus Recklinghausen

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2019-06-13
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

1. Obesity, Classification I-III (BMI>30kg/m²), preexisting for at least 5 years with severe comorbidities
2. Attempted weight loss through conservative methods for at least 6 months with unseccessful results
3. Performing a laparoscopic sleeve gastrectomy to treat morbid obesity
4. Patients' aggrement for follow up tests

Exclusion Criteria

1. Patients younger as 18 years
2. Patients with a BMI <30kg/m²
3. Patients with psycological problems or alcohol/drug addiction

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Proof of Reflux ( symptoms, endoscopical findings), 1 year after performing Sleeve Gastrectomy with the use of questionnaires and upper endoscopy.

Secondary Outcome Measures

Name	Time	Method
Appearance of hiatal herniation, weight loss und assessment of the quality of life, 1 year after Sleeve Gastrectomy with the use of upper endoscopy, weight. measurement of weight and questionnaires.